BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu Y, Yang Z, Jin B, Qin X, Zhu X, Sun J, Huo L, Wang R, Shi Y, Jia Z, Shi YS, Chu S, Kong D, Zhang W. Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2. Pharmacological Research 2020;161:105128. [DOI: 10.1016/j.phrs.2020.105128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Su F, Bai C, Luo Y, Zhang W, Cui N, Wang Y, Sun Y, Zhu W, Zhao M, Yang B, Kuang H, Wang Q. Cattle Bile Arisaema Aqueous Extracts Protect Against Febrile Seizures in Rats Through Regulating Neurotransmitters and Suppressing Neuroinflammation. Front Pharmacol 2022;13:889055. [DOI: 10.3389/fphar.2022.889055] [Reference Citation Analysis]
2 Poulia N, Delis F, Brakatselos C, Ntoulas G, Asprogerakas MZ, Antoniou K. CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration. Front Pharmacol 2021;12:746935. [PMID: 34776964 DOI: 10.3389/fphar.2021.746935] [Reference Citation Analysis]
3 Ji X, Zeng Y, Wu J. The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment. Int J Mol Sci 2021;22:8961. [PMID: 34445666 DOI: 10.3390/ijms22168961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Díaz-Alonso J, Nicoll RA. AMPA receptor trafficking and LTP: Carboxy-termini, amino-termini and TARPs. Neuropharmacology 2021;197:108710. [PMID: 34271016 DOI: 10.1016/j.neuropharm.2021.108710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fallah MS, Dlugosz L, Scott BW, Thompson MD, Burnham WM. Antiseizure effects of the cannabinoids in the amygdala-kindling model. Epilepsia 2021;62:2274-82. [PMID: 34251027 DOI: 10.1111/epi.16973] [Reference Citation Analysis]
6 Franco V, Bialer M, Perucca E. Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research. Neuropharmacology 2021;185:108442. [PMID: 33347884 DOI: 10.1016/j.neuropharm.2020.108442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]